Such in vivo immune modulation by curcumin led to enhanced IFNγ+ CD4 and CD8 T cells with heightened capacity to lyse syngeneic 4T1 tumor cells, resulting in inhibition of tumor growth. This evidence concerns the gene CD4 and neoplasm.